Browsing byAuthorGhassabian, S
Showing results 1 to 6 of 6
Issue Date | Title | Author(s) |
2018-03-01 | Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver | Murray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T |
2016-12-01 | High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC–MS/MS instrumentation | Moosavi, SM; Shekar, K; Fraser, J; Smith, MT; Ghassabian, S |
2012-08-15 | High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS | Ghassabian, S; Moosavi, SM; Valero, YG; Shekar, K; Fraser, JF; Smith, MT |
2018-01-15 | An improved liquid chromatography tandem mass spectrometry (LC–MS/MS) method for quantification of dexmedetomidine concentrations in samples of human plasma | Moosavi, SM; Shekar, K; Fraser, JF; Smith, MT; Ghassabian, S |
2012-07-15 | Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites | Ghassabian, S; Rawling, T; Zhou, F; Doddareddy, MR; Tattam, BN; Hibbs, DE; Edwards, RJ; Cui, PH; Murray, M |
2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |